Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-196276
Filing Date
2012-04-30
Accepted
2012-04-30 16:41:41
Documents
2
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT d262743d10ka.htm 10-K/A 318842
2 RULE 13A-14(A)/15D-14(A) CERTIFICATION d262743dex311.htm EX-31.1 2913
  Complete submission text file 0001193125-12-196276.txt   323048
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35285 | Film No.: 12795652
SIC: 2836 Biological Products, (No Diagnostic Substances)